跳至主要内容
临床试验/CTRI/2024/03/064570
CTRI/2024/03/064570招募中4 期

A prospective, comparative, randomized post-marketing clinical study to evaluate the safety, efficacy and refractive outcome of two different toric Intraocular Lens implanted into patients with cataract and corneal astigmatism. - NI

Biotech vision care pvt ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Unilateral and Bilateral Implantation
  • BCVA to be 0.2 Log Mar or Lower
  • Power withing the range of Investigational IOL
  • Stability of the cornea
  • Patients who have and will attend all follow-up appointments
  • Patients must sign and be given a copy of the written Informed consent form.

排除标准

  • 1. Preoperative ocular pathology
  • 2. Ocular co-morbidities affecting visual outcome
  • 3. Previous intra ocular or corneal surgery
  • 4. Traumatic cataract
  • 5. Corneal Opacities
  • 6. Irregular astigmatism
  • 7. instability of keratometry or biometry measurements;
  • 8. Ophthalmic diseases such as Pseudoexfoliation, glaucoma,
  • traumatic cataract corneal scars and other co-morbidity that
  • could affect capsule bag stability

研究者

发起方
Biotech vision care pvt ltd

相似试验